AI Terminal

MODULE: AI_ANALYST

Interactive Q&A, Risk Assessment, Summarization

MODULE: DATA_EXTRACT

Excel Export, XBRL Parsing, Table Digitization

MODULE: PEER_COMP

Sector Benchmarking, Sentiment Analysis

SYSTEM ACCESS LOCKED

Authenticate / Register Log In

Medistim

Earnings Release • Apr 25, 2019

3662_rns_2019-04-25_8cc14126-8531-45bd-a7b0-8e02a58cb6d1.html

Earnings Release

Open in Viewer

Opens in native device viewer

Results for the first quarter 2019 for Medistim ASA

Sales for the quarter ended at MNOK 88.7 (MNOK 74.1), a 19,7 % increase. The growth was driven by USA where sales increased with 50 % in NOK compared to last year. Currency neutral sales of own products increased with 20.0 %, while currency neutral sales in the US increased with 37.3 %. Strong growth in capital sale of systems in the US contributes to sales growth for the quarter and future increased recurring revenue. Operating profit (EBIT) ended at MNOK 19.9 (MNOK 13.6). The General Meeting decided to pay a dividend of NOK 2.25 per share (NOK 2.00 per share).